4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      An Update on New Generation Transcatheter Aortic Valves and Delivery Systems

      , , , , ,
      Journal of Clinical Medicine
      MDPI AG

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Over the last 15 years, the management of aortic valve disease has been changed by transcatheter aortic valve replacement, which has become the standard of care across the entire spectrum of surgical risk. As a result of continuous evolution of this technique, several next-generation transcatheter heart valves (THVs) have been developed to minimize procedural complications and improve patient outcomes. This review aims to provide an update on the new generation THVs and delivery systems.

          Related collections

          Most cited references50

          • Record: found
          • Abstract: found
          • Article: not found

          Transcatheter Aortic-Valve Replacement with a Self-Expanding Valve in Low-Risk Patients

          Transcatheter aortic-valve replacement (TAVR) is an alternative to surgery in patients with severe aortic stenosis who are at increased risk for death from surgery; less is known about TAVR in low-risk patients.
            Bookmark
            • Record: found
            • Abstract: not found
            • Article: not found

            2020 ACC/AHA guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery.

              This study sought to evaluate the safety and efficacy of the CoreValve transcatheter heart valve (THV) for the treatment of severe aortic stenosis in patients at extreme risk for surgery.
                Bookmark

                Author and article information

                Contributors
                (View ORCID Profile)
                Journal
                JCMOHK
                Journal of Clinical Medicine
                JCM
                MDPI AG
                2077-0383
                February 2022
                January 19 2022
                : 11
                : 3
                : 499
                Article
                10.3390/jcm11030499
                35159952
                36f14a42-9433-4838-b797-f1250556711b
                © 2022

                https://creativecommons.org/licenses/by/4.0/

                History

                Comments

                Comment on this article